Last reviewed: July 20, 2026 Last updated: July 20, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
This makes them a practical option for those wary of needles or looking for a hassle-free delivery system
The clinical trials revealed that the individuals could reduce their body weight by up to 5-15% in the 2-4-month span by using Ozempic and implementing changes in lifestyle
Monitoring for potential drugdrug interactions due to delayed gastric emptying is also critical, particularly for narrowtherapeuticindex agents
5.3 Treatment of diabetic nephropathy with Scrophulariae Radix Diabetic nephropathy, which affects 2040% of individuals with diabetes (127), is a major cause of end-stage renal disease and elevated cardiovascular risk (128)